CDIO | tickerfilter.com

Fundamental analysis

42%

Profitability 35%

Dept financing 26%

Liquidity 50%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-9.50%

1 Month

254.74%

3 Months

28.91%

6 Months

29.32%

1 Year

1,085.37%

2 Year

247.14%

Key data

Stock price

$4.86

P/E Ratio

0.00

DAY RANGE

$4.34 - $5.22

EPS

-$2.07

52 WEEK RANGE

$0.15 - $7.91

52 WEEK CHANGE

$1,108.96

MARKET CAP

7.070 M

YIELD

N/A

SHARES OUTSTANDING

1.826 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

2.95

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,061,002

AVERAGE 30 VOLUME

$10,262,248

Company detail

CEO: Meeshanthini Dogan
Region: US
Website: cardiodiagnosticsinc.com
Employees: 1
IPO year: 2022

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Mana Capital Acquisition Corp. focuses on engaging in a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Dover, Delaware.

CDIO - Cardio Diagnostics Holdings Inc